Penicillium roqueforti: A Rare Fungus Causing Infection in an Immunocompromised Host
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 2
Abstract
Abstract Penicillium roqueforti is a fungus that widely exists in the environment and is often non-pathogenic to humans. However, in immunocompromised hosts, it may be recognized as a cause of systemic mycosis. We report a rare case of mycosis due to Penicillium roqueforti in six-year-old haemato-oncology patient.
Authors and Affiliations
Jisha Asokan, Ajith Kumar Vellani Thamunni, Rema Devi Surendran
Keywords
Related Articles
- EP ID EP508133
- DOI 10.7860/JCDR/2018/30933.11210
- Views 58
- Downloads 0
Effect of Intracuff Inflation with Alkalinised Lignocaine, Saline and Air on Early Postoperative Airway Morbidity-A Randomised Control Trial
ABSTRACT Introduction: Endotracheal intubation is the gold standard of airway management, and usage of the cuffed Endotracheal Tube (ETT) is routine clinical practice. The ETT provides adequate ventilation and reduces as...
Management of Traumatic Fibroma in a Patient with Cerebral Palsy Using 810nm Diode Laser
There are several treatment options for hyperplastic gingival lesions. Among these, diode lasers have the advantages of less bleeding, which is an important characteristic in mucosal lesions, a shorter procedure time, be...
Ball in Right Atrium Cavity: What is your Diagnosis?
Images in Medicine
Cross Sectional Observational Study Performed to See for Relation of Mallampati Score and Extended Mallampati Score with Body Mass Index
Introduction: There is increasing incidence of obesity worldwide. Since obese patients have an increased fatty tissue distributed in a truncal fashion, they may have an important and negative impact on the airway patency...
Does Azithromycin and Cetirizine Combination Given for Upper Respiratory Tract Infections has any Significant Effect on QTc?
Introduction: Azithromycin usage in patients with baseline cardiovascular risk is associated with increased risk of cardiovascular mortality, following which Food and Drug Administration (FDA) issued a black box warning...